Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel...
https://pubmed.ncbi.nlm.nih.gov/33538338Actively Recruiting
Phase Not Applicable
Age: 18Years +
All Genders
ID06630962
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care: A Randomized Control Trial- COST-FIN
Led by Northwestern University · Updated on 2024-10-08
200
Participants Needed
2
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the effectiveness of a structured financial navigation program to reduce financial catastrophe and distress among cancer patients in Nigeria. This trial focuses on newly diagnosed breast, colorectal, or prostate cancer patients, examining if the program can lower the high costs and financial challenges faced by these individuals. The study also evaluates whether the financial navigation program is sustainable and cost-effective for cancer centers in Nigeria. Participants in the financial navigation program will work with a salaried financial navigator who educates them about financial literacy, insurance options, and available charitable payment programs. The navigator also assists with verifying insurance documents, maintaining financial records, and coordinating insurance payments. The trial compares this group to participants receiving routine care without access to the navigator’s services. The study will enroll 200 patients at two cancer centers and follow them over time to assess financial outcomes. Participants will complete surveys about their demographics, cancer history, socioeconomic status, quality of life, psychological wellbeing, and all costs related to their cancer care. The main outcomes measured include the incidence of financial catastrophe over 12 months and levels of financial distress at 3, 6, and 12 months. Researchers will also monitor cost-related non-adherence to treatment up to 6 months. This detailed monitoring aims to provide insights into how financial navigation may affect cancer care affordability and patient wellbeing in low-resource settings.
CONDITIONS
Brief Title
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Age 18 years and older
- Recently diagnosed with breast, colorectal, or prostate cancer within 6 weeks of presentation at the study site
- Have not received definitive chemotherapy, radiotherapy, or major surgery (diagnostic or temporary interventions allowed)
- Candidate for definitive cancer treatment
You will not qualify if you...
- Unable to provide consent
- Has initiated definitive cancer treatment at the study site or elsewhere
- Only receiving best supportive care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Financial Navigation Program or Routine Care
Duration - 12 months
Participants either receive education and assistance through a financial navigator who provides counseling, insurance verification, and payment coordination, or continue with routine care without access to the financial navigator services.
Participants are engaged from enrollment with financial counseling or routine care over this period
Monitoring of Financial Distress and Adherence
Duration - Up to 12 months
Participants are monitored for levels of financial distress and cost-related treatment adherence at multiple timepoints during the study.
Assessments occur at 3, 6, and 12 months after enrollment
Trial Site Locations
Total: 2 locations
1
Obafemi Awolowo University Teaching Hospitals Complex
Ile-Ife, Nigeria
Actively Recruiting
2
Lakeshore Cancer Center
Lagos, Nigeria
Actively Recruiting
Loading map...
Research Team
J
Juliet Lumati
K
Kristina Diaz
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
GLOBOCAN 2018: counting the toll of cancer.
The Lancet
https://pubmed.ncbi.nlm.nih.gov/30264708Data on the survival times of breast cancer patients in a Teaching Hospital, Osogbo.
Phillip Oluwatobi Awodutire, Oladapo Adedayo Kolawole, Oluwatosin Ruth Ilori
https://pubmed.ncbi.nlm.nih.gov/32817870Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria.
Musa Ali-Gombe, Muhammad Inuwa Mustapha, Ayorinde Folasire...
https://pubmed.ncbi.nlm.nih.gov/33889201Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study.
Cricket Gullickson, Michael Goodman, Yvonne W Joko-Fru...
https://pubmed.ncbi.nlm.nih.gov/34164808A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different?
Saurabh Saluja, Olusegun I Alatise, Adisa Adewale...
https://pubmed.ncbi.nlm.nih.gov/24953266Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study.
Tobias P Seraphin, Walburga Y Joko-Fru, Shyam S Manraj...
https://pubmed.ncbi.nlm.nih.gov/34244896Management of prostate cancer in port harcourt, Nigeria: changing patterns.
On Ekeke, Oe Amusan, N Eke
https://pubmed.ncbi.nlm.nih.gov/25452994Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Marzieh Araghi, Melina Arnold, Mark J Rutherford...
https://pubmed.ncbi.nlm.nih.gov/32482683Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo...
https://pubmed.ncbi.nlm.nih.gov/29395269